Stay updated on Durvalumab in Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab in Cervical Cancer Clinical Trial page.
Latest updates to the Durvalumab in Cervical Cancer Clinical Trial page
- Check3 days agoChange DetectedAdded a Locations section with multiple sites (Arizona, California, Florida, Georgia, Michigan, New York, Ohio, Tennessee, Texas, Gurgaon, India 122001) and removed the prior state locations; Revision updated to v3.3.3.SummaryDifference0.5%
- Check11 days agoChange DetectedIndia location listing updated: added Gūrgaon, India, 122001 and removed Gurgaon, India, 122001 (diacritic spelling change).SummaryDifference0.0%
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedAdded an explanatory note that PubMed publications are automatically filled from PubMed and may not relate to the study; updated the page revision to v3.3.2.SummaryDifference0.1%
- Check39 days agoChange DetectedRemoved the government funding notice indicating that information may not be up to date due to funding lapses. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check47 days agoChange DetectedAdded Tainan, Taiwan, 704 as a study site and removed Tainan City, Taiwan, 704 from the locations. This updates the geographic coverage of trial sites for potential participants.SummaryDifference0.0%
- Check54 days agoChange DetectedAdded Gurgaon, India, 122001 as a study site location and removed Gūrgaon, India, 122001. This reflects updated spelling and site listing in the study's locations.SummaryDifference0.0%
Stay in the know with updates to Durvalumab in Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab in Cervical Cancer Clinical Trial page.